Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Not yet recruiting 2Completed 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Thoracic 1Breast 1

Conditions

Neoplasms 1Lung Neoplasms 1Disease 1Breast Neoplasms 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Interventional × Diagnosis × Clear all
NCT00756496 2020-12-07

LIP2SIP

Siemens Medical Solutions USA - CSG

Phase NA Completed
442 enrolled 2 charts
Breast

Breast Neoplasms

NCT03645018 2018-09-14

SOS2

Ospedale Santa Croce-Carle Cuneo

Phase 3 Completed
1,341 enrolled
Thoracic

Disease, Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡